Product Images Levetiracetam

The text seems to contain a table with different percentages related to patients and the use of two medications, Levetiracetam and Placebo. The table shows that 74% of patients had some outcome related to the medication, and that the Levetiracetam Tablet was taken at a higher dosage of 3000 mg/day while Placebo was taken at 1000 mg/day. However, the information is incomplete and confusing without context, so a specific useful description cannot be given.*

This appears to be a chart or a table with columns labeled "Placebo", "Levetiracetam Tablet 1000 mg/day" and "Levetiracetam Tablet 3000 mg/day" and two rows labeled "2R 8 2EF" and "@ = 63% 352% 208%". The numbers in the cells seem to be percentages, suggesting that this is possibly some kind of clinical trial results related to the effectiveness of Levetiracetam on patients. However, without more information it is difficult to say for sure what the data represents or how it was collected.*

This is a comparison of the effectiveness of a placebo (N=111) versus a medication called Levetiracetam Tablet at a dosage of 3000 mg/day (N=180). The percentages 14.4% and 39.4% may possibly refer to the rate of effectiveness of each treatment, but more information is needed to confirm this assumption.*

The text is showing percentages without any context or explanation. Specifically, it displays two percentages side-by-side and then lists the names of two groups (Placebo and Levetiracetam Tablet) with their respective sample sizes (97 and 101). Therefore, without further context and explanation, it is not possible to generate a useful description of this text.*

The given data seems to be a chart showing the percentage of patients on certain medications. The chart shows the percentage of patients on Levetiracetam Tablet and Placebo, with their respective number counts (N=84). There might be some unspecified additional data that is not visible in this text.*

This is a description of a medication called Levetiracetam. Each tablet contains 250 mg of Levetiracetam, USP. The tablets should be stored at a temperature between 20 to 25°C. It is advised that the medication be kept away from children. Additionally, each patient is required to receive a Medication Guide when picking up the medication. The medication is manufactured by Cadila Healthcare Ltd. located in Ahmedabad, India, and distributed by 2 Pt USA Inc.*

Each tablet of this medication contains 1000 mg of Levetracetam, USP. The usual dosage information can be found in the package insert or by referring to NDC 68382-168-14 for complete prescribing guidelines. This medication is dispensed by pharmacists and comes with a medication guide. The tablets are packaged in a bottle with a resistant closure and the lot number is indicated. The manufacturer is Yaus Pharmaceuticals USA Inc. located in Pennington, NJ 08534.*